{
    "data": [
        {
            "id": "67a20fc19d57a90001d4d277",
            "title": "Deep Dive Into Realty Income Stock: Analyst Perspectives (9 Ratings)",
            "description": " ",
            "image": "https://www.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png",
            "link": "https://www.benzinga.com/insights/analyst-ratings/25/02/43460204/deep-dive-into-realty-income-stock-analyst-perspectives-9-ratings",
            "pub_date": "2025-02-04 21:01:57",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a2100d9d57a90001d4d29c",
            "title": "Market Skeptical Of DOGE Hype, Questions Elon Musk&#39;s Execution, Bernstein Says",
            "description": "Asset manager Bernstein reports that the market remains pessimistic about the Department of Government Efficiency (DOGE) initiative, expressing doubts about Elon Muskâ€˜s ability to implement significant changes effectively. ",
            "image": "https://www.benzinga.com/files/images/story/2025/02/04/Dogecoins-Surge--Thanks-to-Elon-Musk-and.jpeg",
            "link": "https://www.benzinga.com/markets/cryptocurrency/25/02/43460243/market-skeptical-of-doge-hype-questions-elon-musks-execution-bernstein-says",
            "pub_date": "2025-02-04 21:03:14",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a210289d57a90001d4d2a3",
            "title": "PepsiCo Q4 Earnings: EPS Beat, Subdued North America Performance, 5% Dividend Hike And More",
            "description": "PepsiCo shares dropped in premarket trading following a weaker-than-expected fourth-quarter revenue report. The company posted a slight sales decline of 0.2%, totaling $27.78 billion, below analyst estimates.",
            "image": "https://www.benzinga.com/files/images/story/2025/02/04/Pepsico-Shutterstock.jpeg",
            "link": "https://www.benzinga.com/25/02/43460249/pepsicos-q4-sales-miss-estimates-on-downcast-performance-in-north-america-stock-dives",
            "pub_date": "2025-02-04 21:03:40",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a20c289d57a90001d4cfdc",
            "title": "Check Point Boosts Threat Prevention with Upgraded Infinity Platform",
            "description": "Check Point Software Technologies Ltd.  shares rise on enhanced cybersecurity capabilities, driven by AI and identity awareness integration.",
            "image": "https://www.benzinga.com/files/images/story/2025/02/04/Cybersecurity-Stock-Poised-To-Surge-As-T_0.jpeg",
            "link": "https://www.benzinga.com/25/02/43459532/check-point-boosts-threat-prevention-with-upgraded-infinity-platform",
            "pub_date": "2025-02-04 20:46:35",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a20c8d9d57a90001d4cff6",
            "title": "Novo Nordisk Faces Investor Concerns Over Hybrid CagriSema Trial Results For Weight Loss",
            "description": "Novo Nordisk&#39;s CagriSema trial raised concerns as patients reported weight loss but significant side effects. Investors question trial protocols and transparency as Novo plans a new study.",
            "image": "https://www.benzinga.com/files/images/story/2025/02/04/Ozempic-maker-Novo-Nordisk.jpeg",
            "link": "https://www.benzinga.com/25/02/43459558/novo-nordisk-faces-investor-concerns-over-hybrid-cagrisema-trial-results-for-weight-loss",
            "pub_date": "2025-02-04 20:48:16",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}